glp-1 layoffs news medications could cut US mortality by 6.4%, new study finds Your Weight-Loss Drugs Are Next

Currently available FDA-approved GLP-1 RAs include several monotherapy agents and one combination multi-agonist, the dual GLP-1/GIP agonist tirzepatide (Zheng et al., 2024)

The observed protective effects are mediated through multiple molecular mechanisms, including enhanced metabolic regulation, direct anti-proliferative actions, and augmented immune surveillance [16, 17]

Available as Saxenda for weight loss and Victoza for diabetes, it requires daily injections rather than weekly ones

Introduction Addiction, as defined by the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), is a chronic, relapsing disorder characterized by compulsive substance use despite harmful consequences [1]

Ideal for those seeking current, actionable clinical strategies for metabolic health and private practice growth

Weight loss has been shown to improve symptoms in women with PCOS, but achieving and maintaining weight loss can be challenging